Caroline Wigerup
About Caroline Wigerup
Caroline Wigerup is the Director of Biology at Acrivon Therapeutics, Inc., where she has worked since 2021. She has extensive experience in the field of biomedicine, having held various positions at Acrivon Therapeutics and Lund University, including roles as Associate Director and Principal Scientist.
Current Role at Acrivon Therapeutics
Caroline Wigerup serves as the Director of Biology at Acrivon Therapeutics, Inc., a position she has held since 2021. In this role, she oversees biological research and development initiatives within the company. Her leadership contributes to advancing the company's mission in the biopharmaceutical sector. Wigerup is based in Lund, Skåne County, Sweden.
Previous Positions at Acrivon Therapeutics
Before her current role, Caroline Wigerup held multiple positions at Acrivon Therapeutics. She was the Associate Director of Biology from 2019 to 2021, where she played a key role in managing biological projects. Prior to that, she worked as a Principal Scientist from 2018 to 2019, focusing on research and development efforts within the organization.
Academic Background
Caroline Wigerup studied at Lund University, where she earned a Master of Science in Biomedicine from 1999 to 2003. She further pursued her education at the same institution, obtaining a Doctor of Philosophy (Ph.D.) in Cancer Biology from 2004 to 2009. Her academic training has provided her with a strong foundation in biomedical sciences.
Research Experience at Lund University
Caroline Wigerup has extensive research experience at Lund University. She served as a Postdoctoral Fellow from 2009 to 2011, followed by a position as a Research Scientist from 2011 to 2017. In 2017, she briefly held the role of Group Leader. Her work at the university contributed to various research initiatives in the field of biomedicine.